| 2023-05-19 | Sale | Laboratory Corporation of America Holdings LH | CEO, Covance Drug Development | 4,300 0.0049% | $216.91 | $932,707 | +13.45% | |
| 2023-02-21 | Sale | Laboratory Corporation of America Holdings LH | CEO, Covance Drug Development | 8,000 0.0092% | $250.58 | $2M | -2.73% | |
| 2021-05-06 | Sale | Laboratory Corporation of America Holdings LH | CEO, Covance Drug Development | 5,000 0.0051% | $276.55 | $1.38M | -0.23% | |
| 2020-11-04 | Sale | Laboratory Corporation of America Holdings LH | CEO, Covance Drug Development | 3,000 0.0031% | $214.14 | $642,407 | +24.6% |